Demonstrating the Impact of Skin Disease through Data GRIDD

Throughout the past six months, the Global Research on the Impact of Dermatological Diseases (GRIDD) team has actively engaged patients around the world in a Delphi process, a key step in developing the Patient-reported Impact of Dermatological Diseases (PRIDD) measure. Thank you to our patient organizations around the world for their help in making the GRIDD Delphi process a success!
Read about how many patients participated and learn about next steps in the project - including cognitive testing with patients in July and August.
Learn more here: globalskin.org...